Company intelligence / Profile preview

Clio

Ownership: Private
Development stage: Commercial

Overview

Clio AI offers an enterprise-grade artificial intelligence platform designed to accelerate innovation in biotechnology and life sciences. Its tools enable semantic search across internal documents, data mining of biomedical datasets, coordination of clinical research studies by streamlining access to protocols and regulatory documents, and secure deployment on private cloud or on-premises infrastructure. The system supports advanced analytics for biomedical data analysts as well as compliance-focused workflows for clinical research teams[1][4].

Industry: Drug Discovery Services

Partnerships

Client base includes consulting firms like Boston Consulting Group using the platform internally

Beyond the preview

Go deeper on Clio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clio.

Explore the full profile